{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:36:21Z","timestamp":1778927781110,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["837001506"],"award-info":[{"award-number":["837001506"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10620-020-06796-0","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T08:02:58Z","timestamp":1614240178000},"page":"4457-4466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-6256","authenticated-orcid":false,"given":"Christina J.","family":"Sperna Weiland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan M. L.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander C.","family":"Poen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels G.","family":"Venneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanin E.","family":"van Hooft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco J.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Verdonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Fockens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost P. H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin J. M.","family":"van Geenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Dutch Pancreatitis Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"6796_CR1","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","volume":"102","author":"A Andriulli","year":"2007","unstructured":"Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781\u20131788.","journal-title":"Am J Gastroenterol"},{"key":"6796_CR2","doi-asserted-by":"publisher","first-page":"143.e9","DOI":"10.1016\/j.gie.2014.06.045","volume":"81","author":"B Kochar","year":"2015","unstructured":"Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81:143.e9\u2013149.e9.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/2050640619834839","volume":"7","author":"XJNM Smeets","year":"2019","unstructured":"Smeets XJNM, Bouhouch N, Buxbaum J, et al. The revised Atlanta criteria more accurately reflect severity of post-ERCP pancreatitis compared to the consensus criteria. United Eur Gastroenterol J. 2019;7:557\u2013564.","journal-title":"United Eur Gastroenterol J"},{"key":"6796_CR4","doi-asserted-by":"publisher","first-page":"E477","DOI":"10.1055\/a-0862-0215","volume":"07","author":"J Serrano","year":"2019","unstructured":"Serrano J, de Moura D, Bernardo W, et al. Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Endosc Int Open. 2019;07:E477\u2013E486.","journal-title":"Endosc Int Open"},{"key":"6796_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.13105\/wjma.v7.i5.249","volume":"7","author":"M Sugimoto","year":"2019","unstructured":"Sugimoto M, Takagi T, Suzuki R, et al. Pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis. World J Meta-Anal. 2019;7:249\u2013258.","journal-title":"World J Meta-Anal"},{"key":"6796_CR6","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/MCG.0000000000000781","volume":"51","author":"ZF Zhang","year":"2017","unstructured":"Zhang ZF, Duan ZJ, Wang LX, Zhao G, Deng WG. Aggressive hydration with lactated ringer solution in prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2017;51:e17\u2013e26.","journal-title":"J Clin Gastroenterol"},{"key":"6796_CR7","first-page":"319","volume":"11","author":"M Hajalikhani","year":"2018","unstructured":"Hajalikhani M, Emami MH, Khodadoostan M, et al. Combination of diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis. Gastroenterol Hepatol Bed Bench. 2018;11:319\u2013324.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"6796_CR8","first-page":"538","volume":"19","author":"M Hosseini","year":"2016","unstructured":"Hosseini M, Shalchiantabrizi P, Yektaroudy K, Dadgarmoghaddam M, Salari M. Prophylactic effect of rectal indomethacin administration, with and without intravenous hydration, on development of endoscopic retrograde cholangiopancreatography pancreatitis episodes: a randomized clinical trial. Arch Iran Med. 2016;19:538\u2013543.","journal-title":"Arch Iran Med"},{"key":"6796_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-018-2583-x","volume":"19","author":"XJNM Smeets","year":"2018","unstructured":"Smeets XJNM, da Costa DW, Fockens P, et al. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial. Trials. 2018;19:1\u20139.","journal-title":"Trials"},{"key":"6796_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-016-1251-2","volume":"17","author":"BJ Elmunzer","year":"2016","unstructured":"Elmunzer BJ, Serrano J, Chak A, et al. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016;17:1\u20136.","journal-title":"Trials"},{"key":"6796_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1055\/s-0034-1377875","volume":"46","author":"JM Dumonceau","year":"2014","unstructured":"Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European society of gastrointestinal endoscopy (ESGE) guideline\u2014updated June 2014. Endoscopy. 2014;46:799\u2013815.","journal-title":"Endoscopy"},{"key":"6796_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","volume":"85","author":"V Chandrasekhara","year":"2017","unstructured":"Chandrasekhara V, Khashab MA, Muthusamy VR, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85:32\u201347.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR13","doi-asserted-by":"crossref","unstructured":"Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52:127\u2013149.","DOI":"10.1055\/a-1075-4080"},{"key":"6796_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1055\/s-0029-1244208","volume":"42","author":"JM Dumonceau","year":"2010","unstructured":"Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42:503\u2013515.","journal-title":"Endoscopy"},{"key":"6796_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/intqhc\/mzg031","volume":"15","author":"K Kelley","year":"2003","unstructured":"Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Heal Care. 2003;15:261\u2013266.","journal-title":"Int J Qual Heal Care"},{"key":"6796_CR16","unstructured":"KNMG. Aantal geregistreerde specialisten\/profielartsen op peildatum 31 December van het jaar. 2018. https:\/\/www.knmg.nl\/web\/file?uuid=ffd10764-12d9-48aa-8514-2df93e523e21&owner=5c945405-d6ca-4deb-aa16-7af2088aa173&contentid=70724&elementid=2112442. Accessed 28 Jun 2020."},{"key":"6796_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.gie.2011.07.010","volume":"75","author":"MA Anderson","year":"2012","unstructured":"Anderson MA, Fisher L, Jain R, et al. ASGE guideline: complications of ERCP. Gastrointest Endosc. 2012;75:467\u2013473.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR18","doi-asserted-by":"publisher","first-page":"934.e2","DOI":"10.1016\/j.gie.2009.10.055","volume":"71","author":"JM Dumonceau","year":"2010","unstructured":"Dumonceau JM, Rigaux J, Kahaleh M, et al. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc. 2010;71:934.e2\u2013939.e2.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/flgastro-2013-100323","volume":"5","author":"MS Hanna","year":"2014","unstructured":"Hanna MS, Portal AJ, Dhanda AD, Przemioslo R. UK wide survey on the prevention of post-ERCP pancreatitis. Frontline Gastroenterol. 2014;5:103\u2013110.","journal-title":"Frontline Gastroenterol"},{"key":"6796_CR20","unstructured":"Zorginstituut Nederland. Medicijnkosten.nl Diclofenac 100\u00a0mg suppository 2020. https:\/\/www.medicijnkosten.nl\/zoeken?trefwoord=diclofenac&orig-trefwoord=diclofenac&vorm=ZETPIL&sterkte=100MG. Accessed 1 Jun 2020."},{"key":"6796_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cgh.2007.09.007","volume":"5","author":"ML Freeman","year":"2007","unstructured":"Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354\u20131365.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6796_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gie.2006.01.058","volume":"64","author":"S Brackbill","year":"2006","unstructured":"Brackbill S, Young S, Schoenfeld P, Elta G. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc. 2006;64:45\u201352.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gie.2014.07.033","volume":"81","author":"NS Choksi","year":"2015","unstructured":"Choksi NS, Fogel EL, Cote GA, et al. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest Endosc. 2015;81:150\u2013155.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.12998\/wjcc.v2.i9.426","volume":"2","author":"Y Sakai","year":"2014","unstructured":"Sakai Y. Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis. World J Clin Cases. 2014;2:426.","journal-title":"World J Clin Cases"},{"key":"6796_CR25","doi-asserted-by":"publisher","first-page":"65.e12","DOI":"10.1016\/j.gie.2011.01.072","volume":"74","author":"GA Cot\u00e9","year":"2011","unstructured":"Cot\u00e9 GA, Keswani RN, Jackson T, et al. Individual and practice differences among physicians who perform ERCP at varying frequency: a national survey. Gastrointest Endosc. 2011;74:65.e12\u201373.e12.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1177\/2050640618804729","volume":"6","author":"Q He","year":"2018","unstructured":"He Q, Wang L, Peng C, et al. Modified prophylactic 5-fr pancreatic duct stent enhances the rate of spontaneous dislodgement: a multicenter randomized controlled trial. United Eur Gastroenterol J. 2018;6:1519\u20131526.","journal-title":"United Eur Gastroenterol J"},{"key":"6796_CR27","doi-asserted-by":"crossref","unstructured":"Avila P, Holmes I, Kouanda A, Arain M, Dai SC. Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists. Gastrointest Endosc. 2020;91:568\u2013573.","DOI":"10.1016\/j.gie.2019.11.013"},{"key":"6796_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.gie.2019.09.008","volume":"91","author":"AC Storm","year":"2020","unstructured":"Storm AC, Abu Dayyeh BK, Petersen BT, et al. Indomethacin for post-ERCP pancreatitis: prophylaxis at what cost? Gastrointest Endosc. 2020;91:207\u2013208.","journal-title":"Gastrointest Endosc"},{"key":"6796_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jamainternmed.2020.0099","volume":"180","author":"BJ Elmunzer","year":"2020","unstructured":"Elmunzer BJ, Hernandez I, Gellad WF. The skyrocketing cost of rectal indomethacin. JAMA Intern Med. 2020;180:631.","journal-title":"JAMA Intern Med"},{"key":"6796_CR30","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1055\/a-1005-6366","volume":"8","author":"B Njei","year":"2020","unstructured":"Njei B, McCarty TR, Muniraj T, et al. Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis. Endosc Int Open. 2020;8:E29\u2013E40.","journal-title":"Endosc Int Open"},{"key":"6796_CR31","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.12659\/MSM.913314","volume":"24","author":"GZ Li","year":"2018","unstructured":"Li GZ, Wang F, Fang J, Zha HL, Zhao Q. Risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis: evidence from 1786 cases. Med Sci Monit. 2018;24:8544\u20138552.","journal-title":"Med Sci Monit"},{"key":"6796_CR32","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1055\/a-0755-7515","volume":"50","author":"R Valori","year":"2018","unstructured":"Valori R, Senore C, de Lange TI, et al. Performance measures for endoscopy services: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative ESGE Quality Improvement Committee (QIC) Endoscopy Service Working Group. Endoscopy. 2018;50:1186\u20131204.","journal-title":"Endoscopy"},{"key":"6796_CR33","first-page":"503","volume":"101","author":"VE Ekkelenkamp","year":"2015","unstructured":"Ekkelenkamp VE, De Man RA, Ter Borg F, et al. Prospective evaluation of ERCP performance: results of a nationwide quality registry. Endoscopy. 2015;101:503\u2013507.","journal-title":"Endoscopy"},{"key":"6796_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ajg.0000000000000623","volume":"115","author":"ZL Smith","year":"2020","unstructured":"Smith ZL, Elmunzer BJ, Cooper GS, Chak A. Real-world practice patterns in the era of rectal indomethacin for prophylaxis against post-ERCP pancreatitis in a high-risk cohort. Am J Gastroenterol. 2020;115:1.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06796-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:22:37Z","timestamp":1636741357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6796"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06796-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Christina J. Sperna Weiland, Megan M.L. Engels, Robert C. Verdonk, Alexander C. Poen, Abha Bhalla, and Niels G. Venneman do not have potential conflicts of interest or disclosures to report. Jeanin E. van Hooft has received research support from Cook Medical and received consultancy fees from Medtronic, Cook Medical, and Boston Scientific. Marco J. Bruno has received research support from Boston Scientific, Cook Medical, Pentax Medical, InterScope, and 3\u00a0M and acted as a consultant for Boston Scientific, Cook Medical, and Pentax Medical; Paul Fockens has received consultancy fees from Cook Medical, Olympus, and Ethicon Endo-Surgery. Joost P.H. Drenth has received research support from Gilead to support Hepatitis C elimination in The Netherlands. Erwin J.M. van Geenen has received research support from Mylan and Olympus and acted as a consultant for MTW-Endoskopie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}